REISS LIMITED

Financial Health Score: B

Explanation: Reiss Limited receives a strong 'B' grade based on the available structural and compliance data. The company exhibits excellent "hygiene" habits—its statutory filings are perfectly up to date, and it possesses over three decades of operational resilience. However, without visible profitability, liquidity, or cash flow metrics—which are exempt from public filing due to its subsidiary status—a complete blood work analysis is restricted, preventing a top-tier 'A' grade.

Key Vital Signs

• Pulse & Respiration (Statutory Compliance): Strong. The company's accounts and confirmation statements are fully up to date, with no overdue filings. This indicates a healthy, regular administrative pulse and a lack of regulatory distress.
• Longevity (Corporate Age): Excellent. Incorporated in 1991, the business has survived multiple economic cycles, retail downturns, and shifting consumer trends. In medical terms, it possesses a highly robust constitution and a strong immune system against market volatility.
• Genetic Lineage (Corporate Structure & PSC): Dependent. Reiss Limited is wholly owned by Reiss (Holdings) Limited, which controls more than 75% of shares and voting rights. As a subsidiary, this patient relies on the broader "family" circulatory system for financial life support and strategic direction.
• Organ Function (Business Operations): Adaptable. With SIC codes covering clothing, footwear, leather goods, and notably, internet retail, the business has developed healthy digital "lungs" to complement its traditional high-street breathing, allowing it to adapt to the modern retail environment.
• Baseline Nutrition (Share Capital): Stable. The issued share capital stands at £265,810, providing a baseline of financial nutrition, though the retained earnings (the body's true fat reserves) are hidden within the group's consolidated accounts.

Diagnosis

Based on the observable symptoms, Reiss Limited is in robust structural health. There are absolutely no red flags for corporate insolvency, distress, or regulatory neglect. The business has a clean bill of health regarding its operational status and director conduct.

However, as an "Audit Exemption Subsidiary," the company is effectively a vital organ within a larger corporate body. Because it files exempt accounts, its individual blood test results—specifically turnover, net current assets, and P&L reserves—are shielded from view. Therefore, while the patient appears fit and active on the outside, an exact diagnosis of its standalone financial vitality cannot be made without accessing the group's consolidated circulatory system. The ultimate financial health of this entity is intrinsically tied to the wellness of its parent holding company.

Recommendations

1. Review the Group's Blood Work: To understand the true financial stamina of Reiss Limited, one must examine the consolidated accounts of Reiss (Holdings) Limited. Review the group's cash flow statements and net current assets to ensure the parent body is pumping sufficient liquidity to all subsidiaries.
2. Monitor the Digital Vitals: The inclusion of internet retail in the business profile is a positive adaptation. Continue to invest in e-commerce capabilities to ensure the business maintains a strong digital immune system against the ongoing decline of physical high-street footfall.
3. Maintain Regulatory Hygiene: The company currently exhibits perfect compliance health. Continue prioritizing timely filings and transparent director responsibilities to avoid unnecessary regulatory "infections" or penalties from Companies House.